nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0942	0.13	CbGbCtD
Clopidogrel—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0657	0.0906	CbGbCtD
Clopidogrel—CYP3A5—Progesterone—uterine cancer	0.0649	0.0895	CbGbCtD
Clopidogrel—CYP2C8—Progesterone—uterine cancer	0.0624	0.086	CbGbCtD
Clopidogrel—CYP2C19—Progesterone—uterine cancer	0.0524	0.0722	CbGbCtD
Clopidogrel—CYP1A2—Progesterone—uterine cancer	0.0483	0.0666	CbGbCtD
Clopidogrel—CYP2C9—Progesterone—uterine cancer	0.0435	0.06	CbGbCtD
Clopidogrel—ABCB1—Progesterone—uterine cancer	0.0423	0.0582	CbGbCtD
Clopidogrel—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0382	0.0527	CbGbCtD
Clopidogrel—ABCB1—Dactinomycin—uterine cancer	0.0335	0.0462	CbGbCtD
Clopidogrel—CYP3A5—Etoposide—uterine cancer	0.0291	0.04	CbGbCtD
Clopidogrel—CYP2C8—Etoposide—uterine cancer	0.0279	0.0385	CbGbCtD
Clopidogrel—CYP3A4—Progesterone—uterine cancer	0.0253	0.0349	CbGbCtD
Clopidogrel—CYP2B6—Doxorubicin—uterine cancer	0.0252	0.0347	CbGbCtD
Clopidogrel—CYP1A2—Etoposide—uterine cancer	0.0216	0.0298	CbGbCtD
Clopidogrel—ABCB1—Etoposide—uterine cancer	0.0189	0.0261	CbGbCtD
Clopidogrel—ABCB1—Doxorubicin—uterine cancer	0.0129	0.0178	CbGbCtD
Clopidogrel—CYP3A4—Etoposide—uterine cancer	0.0113	0.0156	CbGbCtD
Clopidogrel—CYP3A4—Doxorubicin—uterine cancer	0.00773	0.0107	CbGbCtD
Clopidogrel—P2RY12—artery—uterine cancer	0.00605	0.297	CbGeAlD
Clopidogrel—P2RY12—epithelium—uterine cancer	0.00229	0.113	CbGeAlD
Clopidogrel—CES1—female reproductive system—uterine cancer	0.000895	0.044	CbGeAlD
Clopidogrel—CES1—female gonad—uterine cancer	0.000814	0.04	CbGeAlD
Clopidogrel—CYP2C8—renal system—uterine cancer	0.000546	0.0268	CbGeAlD
Clopidogrel—CYP2C8—endometrium—uterine cancer	0.000528	0.0259	CbGeAlD
Clopidogrel—CYP3A5—uterine cervix—uterine cancer	0.000527	0.0259	CbGeAlD
Clopidogrel—CES1—lymph node—uterine cancer	0.000523	0.0257	CbGeAlD
Clopidogrel—CYP1A2—renal system—uterine cancer	0.000511	0.0251	CbGeAlD
Clopidogrel—CYP3A5—renal system—uterine cancer	0.000493	0.0242	CbGeAlD
Clopidogrel—CYP2B6—renal system—uterine cancer	0.00049	0.0241	CbGeAlD
Clopidogrel—CYP2C19—vagina—uterine cancer	0.000453	0.0223	CbGeAlD
Clopidogrel—CYP2C8—female reproductive system—uterine cancer	0.000437	0.0215	CbGeAlD
Clopidogrel—CYP2C8—vagina—uterine cancer	0.000395	0.0194	CbGeAlD
Clopidogrel—CYP2B6—female reproductive system—uterine cancer	0.000392	0.0193	CbGeAlD
Clopidogrel—CYP2C9—female reproductive system—uterine cancer	0.000388	0.0191	CbGeAlD
Clopidogrel—CYP3A4—renal system—uterine cancer	0.00037	0.0182	CbGeAlD
Clopidogrel—ABCB1—myometrium—uterine cancer	0.000359	0.0177	CbGeAlD
Clopidogrel—CYP3A5—female gonad—uterine cancer	0.000359	0.0176	CbGeAlD
Clopidogrel—CYP3A5—vagina—uterine cancer	0.000357	0.0175	CbGeAlD
Clopidogrel—CYP2B6—vagina—uterine cancer	0.000355	0.0174	CbGeAlD
Clopidogrel—CYP3A4—female reproductive system—uterine cancer	0.000296	0.0145	CbGeAlD
Clopidogrel—ABCB1—epithelium—uterine cancer	0.000282	0.0139	CbGeAlD
Clopidogrel—ABCB1—uterine cervix—uterine cancer	0.00028	0.0137	CbGeAlD
Clopidogrel—ABCB1—decidua—uterine cancer	0.000267	0.0131	CbGeAlD
Clopidogrel—ABCB1—renal system—uterine cancer	0.000262	0.0129	CbGeAlD
Clopidogrel—ABCB1—endometrium—uterine cancer	0.000253	0.0124	CbGeAlD
Clopidogrel—Vascular purpura—Doxorubicin—uterine cancer	0.000248	0.00102	CcSEcCtD
Clopidogrel—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000248	0.00102	CcSEcCtD
Clopidogrel—Muscle spasms—Etoposide—uterine cancer	0.000248	0.00102	CcSEcCtD
Clopidogrel—Eczema—Doxorubicin—uterine cancer	0.000247	0.00102	CcSEcCtD
Clopidogrel—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000247	0.00102	CcSEcCtD
Clopidogrel—Hypoglycaemia—Epirubicin—uterine cancer	0.000246	0.00102	CcSEcCtD
Clopidogrel—Cardiac failure—Epirubicin—uterine cancer	0.000246	0.00102	CcSEcCtD
Clopidogrel—ABCB1—mammalian vulva—uterine cancer	0.000245	0.012	CbGeAlD
Clopidogrel—Nausea—Progesterone—uterine cancer	0.000245	0.00101	CcSEcCtD
Clopidogrel—Renal failure acute—Doxorubicin—uterine cancer	0.000241	0.000993	CcSEcCtD
Clopidogrel—Osteoarthritis—Epirubicin—uterine cancer	0.00024	0.000991	CcSEcCtD
Clopidogrel—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.00024	0.000991	CcSEcCtD
Clopidogrel—Feeling abnormal—Dactinomycin—uterine cancer	0.00024	0.000989	CcSEcCtD
Clopidogrel—Anaemia—Etoposide—uterine cancer	0.000238	0.000984	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000238	0.000982	CcSEcCtD
Clopidogrel—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000237	0.000979	CcSEcCtD
Clopidogrel—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000235	0.00097	CcSEcCtD
Clopidogrel—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000235	0.00097	CcSEcCtD
Clopidogrel—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000234	0.000964	CcSEcCtD
Clopidogrel—Renal impairment—Doxorubicin—uterine cancer	0.000233	0.000963	CcSEcCtD
Clopidogrel—ABCB1—uterus—uterine cancer	0.000233	0.0115	CbGeAlD
Clopidogrel—Dermatitis bullous—Doxorubicin—uterine cancer	0.000232	0.000959	CcSEcCtD
Clopidogrel—Vertigo—Etoposide—uterine cancer	0.000232	0.000956	CcSEcCtD
Clopidogrel—Leukopenia—Etoposide—uterine cancer	0.000231	0.000953	CcSEcCtD
Clopidogrel—Purpura—Doxorubicin—uterine cancer	0.000231	0.000951	CcSEcCtD
Clopidogrel—Body temperature increased—Dactinomycin—uterine cancer	0.00023	0.000949	CcSEcCtD
Clopidogrel—Abdominal pain—Dactinomycin—uterine cancer	0.00023	0.000949	CcSEcCtD
Clopidogrel—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00023	0.000947	CcSEcCtD
Clopidogrel—Cardiac failure—Doxorubicin—uterine cancer	0.000228	0.00094	CcSEcCtD
Clopidogrel—Hypoglycaemia—Doxorubicin—uterine cancer	0.000228	0.00094	CcSEcCtD
Clopidogrel—Loss of consciousness—Etoposide—uterine cancer	0.000227	0.000936	CcSEcCtD
Clopidogrel—Cough—Etoposide—uterine cancer	0.000225	0.000929	CcSEcCtD
Clopidogrel—Blood creatinine increased—Epirubicin—uterine cancer	0.000225	0.000928	CcSEcCtD
Clopidogrel—Hypertension—Etoposide—uterine cancer	0.000223	0.000919	CcSEcCtD
Clopidogrel—Osteoarthritis—Doxorubicin—uterine cancer	0.000222	0.000917	CcSEcCtD
Clopidogrel—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000222	0.000917	CcSEcCtD
Clopidogrel—Liver function test abnormal—Epirubicin—uterine cancer	0.000222	0.000915	CcSEcCtD
Clopidogrel—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000222	0.000914	CcSEcCtD
Clopidogrel—Chest pain—Etoposide—uterine cancer	0.00022	0.000906	CcSEcCtD
Clopidogrel—Abdominal pain upper—Epirubicin—uterine cancer	0.000219	0.000905	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000218	0.0009	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000216	0.000892	CcSEcCtD
Clopidogrel—Hypersensitivity—Dactinomycin—uterine cancer	0.000214	0.000884	CcSEcCtD
Clopidogrel—Gastritis—Epirubicin—uterine cancer	0.000213	0.000877	CcSEcCtD
Clopidogrel—Confusional state—Etoposide—uterine cancer	0.000212	0.000876	CcSEcCtD
Clopidogrel—Anaphylactic shock—Etoposide—uterine cancer	0.000211	0.000869	CcSEcCtD
Clopidogrel—ABCB1—female reproductive system—uterine cancer	0.00021	0.0103	CbGeAlD
Clopidogrel—Infection—Etoposide—uterine cancer	0.000209	0.000863	CcSEcCtD
Clopidogrel—Abdominal distension—Epirubicin—uterine cancer	0.000209	0.000862	CcSEcCtD
Clopidogrel—Asthenia—Dactinomycin—uterine cancer	0.000209	0.000861	CcSEcCtD
Clopidogrel—Blood creatinine increased—Doxorubicin—uterine cancer	0.000208	0.000859	CcSEcCtD
Clopidogrel—Asthma—Epirubicin—uterine cancer	0.000208	0.000856	CcSEcCtD
Clopidogrel—Eosinophilia—Epirubicin—uterine cancer	0.000206	0.000848	CcSEcCtD
Clopidogrel—Liver function test abnormal—Doxorubicin—uterine cancer	0.000205	0.000847	CcSEcCtD
Clopidogrel—Skin disorder—Etoposide—uterine cancer	0.000205	0.000844	CcSEcCtD
Clopidogrel—Pancreatitis—Epirubicin—uterine cancer	0.000204	0.00084	CcSEcCtD
Clopidogrel—Abdominal pain upper—Doxorubicin—uterine cancer	0.000203	0.000837	CcSEcCtD
Clopidogrel—Angina pectoris—Epirubicin—uterine cancer	0.000202	0.000834	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.0002	0.000826	CcSEcCtD
Clopidogrel—Bronchitis—Epirubicin—uterine cancer	0.0002	0.000824	CcSEcCtD
Clopidogrel—Diarrhoea—Dactinomycin—uterine cancer	0.000199	0.000821	CcSEcCtD
Clopidogrel—Pancytopenia—Epirubicin—uterine cancer	0.000197	0.000813	CcSEcCtD
Clopidogrel—Hypotension—Etoposide—uterine cancer	0.000197	0.000812	CcSEcCtD
Clopidogrel—Gastritis—Doxorubicin—uterine cancer	0.000197	0.000811	CcSEcCtD
Clopidogrel—Neutropenia—Epirubicin—uterine cancer	0.000194	0.000801	CcSEcCtD
Clopidogrel—Abdominal distension—Doxorubicin—uterine cancer	0.000193	0.000798	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000193	0.000796	CcSEcCtD
Clopidogrel—Asthma—Doxorubicin—uterine cancer	0.000192	0.000792	CcSEcCtD
Clopidogrel—ABCB1—female gonad—uterine cancer	0.000191	0.00937	CbGeAlD
Clopidogrel—Eosinophilia—Doxorubicin—uterine cancer	0.00019	0.000785	CcSEcCtD
Clopidogrel—ABCB1—vagina—uterine cancer	0.00019	0.00931	CbGeAlD
Clopidogrel—Paraesthesia—Etoposide—uterine cancer	0.000189	0.00078	CcSEcCtD
Clopidogrel—Pancreatitis—Doxorubicin—uterine cancer	0.000188	0.000777	CcSEcCtD
Clopidogrel—Dyspnoea—Etoposide—uterine cancer	0.000188	0.000775	CcSEcCtD
Clopidogrel—Angina pectoris—Doxorubicin—uterine cancer	0.000187	0.000772	CcSEcCtD
Clopidogrel—Pneumonia—Epirubicin—uterine cancer	0.000186	0.000768	CcSEcCtD
Clopidogrel—Vomiting—Dactinomycin—uterine cancer	0.000185	0.000763	CcSEcCtD
Clopidogrel—Bronchitis—Doxorubicin—uterine cancer	0.000185	0.000762	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000183	0.000757	CcSEcCtD
Clopidogrel—Rash—Dactinomycin—uterine cancer	0.000183	0.000757	CcSEcCtD
Clopidogrel—Pancytopenia—Doxorubicin—uterine cancer	0.000182	0.000753	CcSEcCtD
Clopidogrel—Renal failure—Epirubicin—uterine cancer	0.000182	0.000751	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Etoposide—uterine cancer	0.000182	0.00075	CcSEcCtD
Clopidogrel—Fatigue—Etoposide—uterine cancer	0.000182	0.000749	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Epirubicin—uterine cancer	0.000181	0.000749	CcSEcCtD
Clopidogrel—Stomatitis—Epirubicin—uterine cancer	0.00018	0.000744	CcSEcCtD
Clopidogrel—Pain—Etoposide—uterine cancer	0.00018	0.000743	CcSEcCtD
Clopidogrel—Constipation—Etoposide—uterine cancer	0.00018	0.000743	CcSEcCtD
Clopidogrel—Conjunctivitis—Epirubicin—uterine cancer	0.00018	0.000742	CcSEcCtD
Clopidogrel—Urinary tract infection—Epirubicin—uterine cancer	0.00018	0.000742	CcSEcCtD
Clopidogrel—Neutropenia—Doxorubicin—uterine cancer	0.00018	0.000741	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000178	0.000737	CcSEcCtD
Clopidogrel—Haematuria—Epirubicin—uterine cancer	0.000176	0.000728	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Epirubicin—uterine cancer	0.000175	0.000722	CcSEcCtD
Clopidogrel—Epistaxis—Epirubicin—uterine cancer	0.000175	0.00072	CcSEcCtD
Clopidogrel—Sinusitis—Epirubicin—uterine cancer	0.000174	0.000716	CcSEcCtD
Clopidogrel—Feeling abnormal—Etoposide—uterine cancer	0.000174	0.000716	CcSEcCtD
Clopidogrel—Nausea—Dactinomycin—uterine cancer	0.000173	0.000713	CcSEcCtD
Clopidogrel—Agranulocytosis—Epirubicin—uterine cancer	0.000173	0.000713	CcSEcCtD
Clopidogrel—Pneumonia—Doxorubicin—uterine cancer	0.000172	0.000711	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Etoposide—uterine cancer	0.000172	0.00071	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00017	0.000701	CcSEcCtD
Clopidogrel—Renal failure—Doxorubicin—uterine cancer	0.000168	0.000695	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000168	0.000693	CcSEcCtD
Clopidogrel—Urticaria—Etoposide—uterine cancer	0.000167	0.00069	CcSEcCtD
Clopidogrel—Haemoglobin—Epirubicin—uterine cancer	0.000167	0.000689	CcSEcCtD
Clopidogrel—Stomatitis—Doxorubicin—uterine cancer	0.000167	0.000689	CcSEcCtD
Clopidogrel—Rhinitis—Epirubicin—uterine cancer	0.000167	0.000687	CcSEcCtD
Clopidogrel—Abdominal pain—Etoposide—uterine cancer	0.000166	0.000687	CcSEcCtD
Clopidogrel—Body temperature increased—Etoposide—uterine cancer	0.000166	0.000687	CcSEcCtD
Clopidogrel—Urinary tract infection—Doxorubicin—uterine cancer	0.000166	0.000687	CcSEcCtD
Clopidogrel—Conjunctivitis—Doxorubicin—uterine cancer	0.000166	0.000687	CcSEcCtD
Clopidogrel—Haemorrhage—Epirubicin—uterine cancer	0.000166	0.000686	CcSEcCtD
Clopidogrel—Hepatitis—Epirubicin—uterine cancer	0.000166	0.000686	CcSEcCtD
Clopidogrel—Hypoaesthesia—Epirubicin—uterine cancer	0.000165	0.000682	CcSEcCtD
Clopidogrel—Urinary tract disorder—Epirubicin—uterine cancer	0.000164	0.000677	CcSEcCtD
Clopidogrel—Oedema peripheral—Epirubicin—uterine cancer	0.000164	0.000675	CcSEcCtD
Clopidogrel—Haematuria—Doxorubicin—uterine cancer	0.000163	0.000674	CcSEcCtD
Clopidogrel—Urethral disorder—Epirubicin—uterine cancer	0.000163	0.000672	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000162	0.000668	CcSEcCtD
Clopidogrel—Epistaxis—Doxorubicin—uterine cancer	0.000162	0.000666	CcSEcCtD
Clopidogrel—Sinusitis—Doxorubicin—uterine cancer	0.000161	0.000663	CcSEcCtD
Clopidogrel—Visual impairment—Epirubicin—uterine cancer	0.00016	0.000661	CcSEcCtD
Clopidogrel—Agranulocytosis—Doxorubicin—uterine cancer	0.00016	0.000659	CcSEcCtD
Clopidogrel—Erythema multiforme—Epirubicin—uterine cancer	0.000157	0.000648	CcSEcCtD
Clopidogrel—Eye disorder—Epirubicin—uterine cancer	0.000155	0.000641	CcSEcCtD
Clopidogrel—Hypersensitivity—Etoposide—uterine cancer	0.000155	0.00064	CcSEcCtD
Clopidogrel—Tinnitus—Epirubicin—uterine cancer	0.000155	0.000639	CcSEcCtD
Clopidogrel—Haemoglobin—Doxorubicin—uterine cancer	0.000155	0.000638	CcSEcCtD
Clopidogrel—Rhinitis—Doxorubicin—uterine cancer	0.000154	0.000636	CcSEcCtD
Clopidogrel—Haemorrhage—Doxorubicin—uterine cancer	0.000154	0.000634	CcSEcCtD
Clopidogrel—Hepatitis—Doxorubicin—uterine cancer	0.000154	0.000634	CcSEcCtD
Clopidogrel—Hypoaesthesia—Doxorubicin—uterine cancer	0.000153	0.000631	CcSEcCtD
Clopidogrel—Urinary tract disorder—Doxorubicin—uterine cancer	0.000152	0.000626	CcSEcCtD
Clopidogrel—Oedema peripheral—Doxorubicin—uterine cancer	0.000151	0.000625	CcSEcCtD
Clopidogrel—Asthenia—Etoposide—uterine cancer	0.000151	0.000623	CcSEcCtD
Clopidogrel—Angiopathy—Epirubicin—uterine cancer	0.000151	0.000622	CcSEcCtD
Clopidogrel—Urethral disorder—Doxorubicin—uterine cancer	0.000151	0.000622	CcSEcCtD
Clopidogrel—Immune system disorder—Epirubicin—uterine cancer	0.00015	0.000619	CcSEcCtD
Clopidogrel—Mediastinal disorder—Epirubicin—uterine cancer	0.00015	0.000618	CcSEcCtD
Clopidogrel—Pruritus—Etoposide—uterine cancer	0.000149	0.000615	CcSEcCtD
Clopidogrel—Visual impairment—Doxorubicin—uterine cancer	0.000148	0.000611	CcSEcCtD
Clopidogrel—Mental disorder—Epirubicin—uterine cancer	0.000146	0.000601	CcSEcCtD
Clopidogrel—Erythema multiforme—Doxorubicin—uterine cancer	0.000145	0.0006	CcSEcCtD
Clopidogrel—Malnutrition—Epirubicin—uterine cancer	0.000145	0.000597	CcSEcCtD
Clopidogrel—Diarrhoea—Etoposide—uterine cancer	0.000144	0.000594	CcSEcCtD
Clopidogrel—Eye disorder—Doxorubicin—uterine cancer	0.000144	0.000593	CcSEcCtD
Clopidogrel—Tinnitus—Doxorubicin—uterine cancer	0.000143	0.000591	CcSEcCtD
Clopidogrel—Flatulence—Epirubicin—uterine cancer	0.000143	0.000588	CcSEcCtD
Clopidogrel—Back pain—Epirubicin—uterine cancer	0.00014	0.000577	CcSEcCtD
Clopidogrel—Angiopathy—Doxorubicin—uterine cancer	0.000139	0.000575	CcSEcCtD
Clopidogrel—Dizziness—Etoposide—uterine cancer	0.000139	0.000575	CcSEcCtD
Clopidogrel—Muscle spasms—Epirubicin—uterine cancer	0.000139	0.000574	CcSEcCtD
Clopidogrel—Immune system disorder—Doxorubicin—uterine cancer	0.000139	0.000573	CcSEcCtD
Clopidogrel—Mediastinal disorder—Doxorubicin—uterine cancer	0.000139	0.000572	CcSEcCtD
Clopidogrel—Mental disorder—Doxorubicin—uterine cancer	0.000135	0.000556	CcSEcCtD
Clopidogrel—Vomiting—Etoposide—uterine cancer	0.000134	0.000552	CcSEcCtD
Clopidogrel—Malnutrition—Doxorubicin—uterine cancer	0.000134	0.000552	CcSEcCtD
Clopidogrel—Anaemia—Epirubicin—uterine cancer	0.000134	0.000552	CcSEcCtD
Clopidogrel—Rash—Etoposide—uterine cancer	0.000133	0.000548	CcSEcCtD
Clopidogrel—Dermatitis—Etoposide—uterine cancer	0.000133	0.000547	CcSEcCtD
Clopidogrel—Headache—Etoposide—uterine cancer	0.000132	0.000544	CcSEcCtD
Clopidogrel—Flatulence—Doxorubicin—uterine cancer	0.000132	0.000544	CcSEcCtD
Clopidogrel—Vertigo—Epirubicin—uterine cancer	0.00013	0.000536	CcSEcCtD
Clopidogrel—Syncope—Epirubicin—uterine cancer	0.00013	0.000535	CcSEcCtD
Clopidogrel—Leukopenia—Epirubicin—uterine cancer	0.000129	0.000534	CcSEcCtD
Clopidogrel—Back pain—Doxorubicin—uterine cancer	0.000129	0.000534	CcSEcCtD
Clopidogrel—Muscle spasms—Doxorubicin—uterine cancer	0.000129	0.000531	CcSEcCtD
Clopidogrel—Palpitations—Epirubicin—uterine cancer	0.000128	0.000527	CcSEcCtD
Clopidogrel—Loss of consciousness—Epirubicin—uterine cancer	0.000127	0.000525	CcSEcCtD
Clopidogrel—Cough—Epirubicin—uterine cancer	0.000126	0.000521	CcSEcCtD
Clopidogrel—Nausea—Etoposide—uterine cancer	0.000125	0.000516	CcSEcCtD
Clopidogrel—Hypertension—Epirubicin—uterine cancer	0.000125	0.000515	CcSEcCtD
Clopidogrel—Anaemia—Doxorubicin—uterine cancer	0.000124	0.00051	CcSEcCtD
Clopidogrel—Chest pain—Epirubicin—uterine cancer	0.000123	0.000508	CcSEcCtD
Clopidogrel—Myalgia—Epirubicin—uterine cancer	0.000123	0.000508	CcSEcCtD
Clopidogrel—Arthralgia—Epirubicin—uterine cancer	0.000123	0.000508	CcSEcCtD
Clopidogrel—Anxiety—Epirubicin—uterine cancer	0.000123	0.000506	CcSEcCtD
Clopidogrel—ABCB1—lymph node—uterine cancer	0.000123	0.00602	CbGeAlD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000122	0.000505	CcSEcCtD
Clopidogrel—Vertigo—Doxorubicin—uterine cancer	0.00012	0.000496	CcSEcCtD
Clopidogrel—Syncope—Doxorubicin—uterine cancer	0.00012	0.000495	CcSEcCtD
Clopidogrel—Leukopenia—Doxorubicin—uterine cancer	0.00012	0.000494	CcSEcCtD
Clopidogrel—Confusional state—Epirubicin—uterine cancer	0.000119	0.000491	CcSEcCtD
Clopidogrel—Palpitations—Doxorubicin—uterine cancer	0.000118	0.000488	CcSEcCtD
Clopidogrel—Oedema—Epirubicin—uterine cancer	0.000118	0.000487	CcSEcCtD
Clopidogrel—Anaphylactic shock—Epirubicin—uterine cancer	0.000118	0.000487	CcSEcCtD
Clopidogrel—Loss of consciousness—Doxorubicin—uterine cancer	0.000118	0.000485	CcSEcCtD
Clopidogrel—Infection—Epirubicin—uterine cancer	0.000117	0.000484	CcSEcCtD
Clopidogrel—Cough—Doxorubicin—uterine cancer	0.000117	0.000482	CcSEcCtD
Clopidogrel—Shock—Epirubicin—uterine cancer	0.000116	0.000479	CcSEcCtD
Clopidogrel—Nervous system disorder—Epirubicin—uterine cancer	0.000116	0.000478	CcSEcCtD
Clopidogrel—Hypertension—Doxorubicin—uterine cancer	0.000116	0.000477	CcSEcCtD
Clopidogrel—Skin disorder—Epirubicin—uterine cancer	0.000115	0.000473	CcSEcCtD
Clopidogrel—Myalgia—Doxorubicin—uterine cancer	0.000114	0.00047	CcSEcCtD
Clopidogrel—Chest pain—Doxorubicin—uterine cancer	0.000114	0.00047	CcSEcCtD
Clopidogrel—Arthralgia—Doxorubicin—uterine cancer	0.000114	0.00047	CcSEcCtD
Clopidogrel—Anxiety—Doxorubicin—uterine cancer	0.000114	0.000468	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000113	0.000467	CcSEcCtD
Clopidogrel—Hypotension—Epirubicin—uterine cancer	0.00011	0.000455	CcSEcCtD
Clopidogrel—Confusional state—Doxorubicin—uterine cancer	0.00011	0.000454	CcSEcCtD
Clopidogrel—Oedema—Doxorubicin—uterine cancer	0.000109	0.000451	CcSEcCtD
Clopidogrel—Anaphylactic shock—Doxorubicin—uterine cancer	0.000109	0.000451	CcSEcCtD
Clopidogrel—Infection—Doxorubicin—uterine cancer	0.000109	0.000448	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000108	0.000444	CcSEcCtD
Clopidogrel—Shock—Doxorubicin—uterine cancer	0.000107	0.000443	CcSEcCtD
Clopidogrel—Nervous system disorder—Doxorubicin—uterine cancer	0.000107	0.000442	CcSEcCtD
Clopidogrel—Insomnia—Epirubicin—uterine cancer	0.000107	0.000441	CcSEcCtD
Clopidogrel—Skin disorder—Doxorubicin—uterine cancer	0.000106	0.000438	CcSEcCtD
Clopidogrel—Paraesthesia—Epirubicin—uterine cancer	0.000106	0.000437	CcSEcCtD
Clopidogrel—Dyspnoea—Epirubicin—uterine cancer	0.000105	0.000434	CcSEcCtD
Clopidogrel—Dyspepsia—Epirubicin—uterine cancer	0.000104	0.000429	CcSEcCtD
Clopidogrel—Hypotension—Doxorubicin—uterine cancer	0.000102	0.000421	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000102	0.00042	CcSEcCtD
Clopidogrel—Fatigue—Epirubicin—uterine cancer	0.000102	0.00042	CcSEcCtD
Clopidogrel—Pain—Epirubicin—uterine cancer	0.000101	0.000416	CcSEcCtD
Clopidogrel—Constipation—Epirubicin—uterine cancer	0.000101	0.000416	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Doxorubicin—uterine cancer	9.95e-05	0.000411	CcSEcCtD
Clopidogrel—Insomnia—Doxorubicin—uterine cancer	9.88e-05	0.000408	CcSEcCtD
Clopidogrel—Paraesthesia—Doxorubicin—uterine cancer	9.81e-05	0.000405	CcSEcCtD
Clopidogrel—Dyspnoea—Doxorubicin—uterine cancer	9.74e-05	0.000402	CcSEcCtD
Clopidogrel—Feeling abnormal—Epirubicin—uterine cancer	9.73e-05	0.000401	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Epirubicin—uterine cancer	9.65e-05	0.000398	CcSEcCtD
Clopidogrel—Dyspepsia—Doxorubicin—uterine cancer	9.61e-05	0.000397	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Doxorubicin—uterine cancer	9.43e-05	0.000389	CcSEcCtD
Clopidogrel—Fatigue—Doxorubicin—uterine cancer	9.42e-05	0.000389	CcSEcCtD
Clopidogrel—Urticaria—Epirubicin—uterine cancer	9.38e-05	0.000387	CcSEcCtD
Clopidogrel—Constipation—Doxorubicin—uterine cancer	9.34e-05	0.000385	CcSEcCtD
Clopidogrel—Pain—Doxorubicin—uterine cancer	9.34e-05	0.000385	CcSEcCtD
Clopidogrel—Body temperature increased—Epirubicin—uterine cancer	9.33e-05	0.000385	CcSEcCtD
Clopidogrel—Abdominal pain—Epirubicin—uterine cancer	9.33e-05	0.000385	CcSEcCtD
Clopidogrel—Feeling abnormal—Doxorubicin—uterine cancer	9e-05	0.000371	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Doxorubicin—uterine cancer	8.93e-05	0.000369	CcSEcCtD
Clopidogrel—Hypersensitivity—Epirubicin—uterine cancer	8.7e-05	0.000359	CcSEcCtD
Clopidogrel—Urticaria—Doxorubicin—uterine cancer	8.68e-05	0.000358	CcSEcCtD
Clopidogrel—Abdominal pain—Doxorubicin—uterine cancer	8.63e-05	0.000356	CcSEcCtD
Clopidogrel—Body temperature increased—Doxorubicin—uterine cancer	8.63e-05	0.000356	CcSEcCtD
Clopidogrel—Asthenia—Epirubicin—uterine cancer	8.47e-05	0.000349	CcSEcCtD
Clopidogrel—Pruritus—Epirubicin—uterine cancer	8.35e-05	0.000345	CcSEcCtD
Clopidogrel—Diarrhoea—Epirubicin—uterine cancer	8.08e-05	0.000333	CcSEcCtD
Clopidogrel—Hypersensitivity—Doxorubicin—uterine cancer	8.05e-05	0.000332	CcSEcCtD
Clopidogrel—Asthenia—Doxorubicin—uterine cancer	7.84e-05	0.000323	CcSEcCtD
Clopidogrel—Dizziness—Epirubicin—uterine cancer	7.81e-05	0.000322	CcSEcCtD
Clopidogrel—Pruritus—Doxorubicin—uterine cancer	7.73e-05	0.000319	CcSEcCtD
Clopidogrel—Vomiting—Epirubicin—uterine cancer	7.5e-05	0.00031	CcSEcCtD
Clopidogrel—Diarrhoea—Doxorubicin—uterine cancer	7.47e-05	0.000308	CcSEcCtD
Clopidogrel—Rash—Epirubicin—uterine cancer	7.44e-05	0.000307	CcSEcCtD
Clopidogrel—Dermatitis—Epirubicin—uterine cancer	7.44e-05	0.000307	CcSEcCtD
Clopidogrel—Headache—Epirubicin—uterine cancer	7.39e-05	0.000305	CcSEcCtD
Clopidogrel—Dizziness—Doxorubicin—uterine cancer	7.22e-05	0.000298	CcSEcCtD
Clopidogrel—Nausea—Epirubicin—uterine cancer	7.01e-05	0.000289	CcSEcCtD
Clopidogrel—Vomiting—Doxorubicin—uterine cancer	6.94e-05	0.000287	CcSEcCtD
Clopidogrel—Rash—Doxorubicin—uterine cancer	6.89e-05	0.000284	CcSEcCtD
Clopidogrel—Dermatitis—Doxorubicin—uterine cancer	6.88e-05	0.000284	CcSEcCtD
Clopidogrel—Headache—Doxorubicin—uterine cancer	6.84e-05	0.000282	CcSEcCtD
Clopidogrel—Nausea—Doxorubicin—uterine cancer	6.49e-05	0.000268	CcSEcCtD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	2.4e-05	0.00204	CbGpPWpGaD
Clopidogrel—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	2.33e-05	0.00198	CbGpPWpGaD
Clopidogrel—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	2.3e-05	0.00195	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.29e-05	0.00195	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	2.28e-05	0.00193	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	2.28e-05	0.00193	CbGpPWpGaD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—AKT1—uterine cancer	2.26e-05	0.00192	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.23e-05	0.00189	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.23e-05	0.00189	CbGpPWpGaD
Clopidogrel—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.22e-05	0.00188	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—CXCL8—uterine cancer	2.16e-05	0.00183	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	2.16e-05	0.00183	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	2.14e-05	0.00181	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	2.13e-05	0.00181	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—AKR1C3—uterine cancer	2.1e-05	0.00179	CbGpPWpGaD
Clopidogrel—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.09e-05	0.00177	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.07e-05	0.00175	CbGpPWpGaD
Clopidogrel—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.06e-05	0.00175	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.06e-05	0.00174	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PGR—uterine cancer	2.05e-05	0.00174	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.03e-05	0.00172	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.03e-05	0.00172	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	2.03e-05	0.00172	CbGpPWpGaD
Clopidogrel—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	1.99e-05	0.00169	CbGpPWpGaD
Clopidogrel—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	1.96e-05	0.00167	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—YWHAE—uterine cancer	1.96e-05	0.00166	CbGpPWpGaD
Clopidogrel—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	1.94e-05	0.00165	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—EP300—uterine cancer	1.93e-05	0.00164	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—FBXW7—uterine cancer	1.88e-05	0.00159	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	1.83e-05	0.00156	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.83e-05	0.00155	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—VEGFA—uterine cancer	1.83e-05	0.00155	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—SRD5A2—uterine cancer	1.82e-05	0.00154	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—NDUFB11—uterine cancer	1.82e-05	0.00154	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—NRAS—uterine cancer	1.8e-05	0.00153	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—NDUFB11—uterine cancer	1.78e-05	0.00151	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—SRD5A2—uterine cancer	1.78e-05	0.00151	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—VEGFA—uterine cancer	1.75e-05	0.00149	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.74e-05	0.00147	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.74e-05	0.00147	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—STK11—uterine cancer	1.64e-05	0.00139	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.64e-05	0.00139	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—CCL2—uterine cancer	1.63e-05	0.00138	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	1.56e-05	0.00132	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—KRAS—uterine cancer	1.55e-05	0.00132	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—SRD5A2—uterine cancer	1.54e-05	0.0013	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—NDUFB11—uterine cancer	1.54e-05	0.0013	CbGpPWpGaD
Clopidogrel—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.54e-05	0.0013	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—SOCS3—uterine cancer	1.53e-05	0.0013	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.53e-05	0.0013	CbGpPWpGaD
Clopidogrel—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.51e-05	0.00129	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.49e-05	0.00127	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.49e-05	0.00127	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CDKN2B—uterine cancer	1.47e-05	0.00125	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IGF1R—uterine cancer	1.43e-05	0.00121	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—PIK3CA—uterine cancer	1.43e-05	0.00121	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—CXCL8—uterine cancer	1.42e-05	0.00121	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.41e-05	0.0012	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—TP53—uterine cancer	1.38e-05	0.00117	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—NDUFB11—uterine cancer	1.37e-05	0.00116	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—SRD5A2—uterine cancer	1.37e-05	0.00116	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—SMAD3—uterine cancer	1.34e-05	0.00114	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—NDUFB11—uterine cancer	1.34e-05	0.00114	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—SRD5A2—uterine cancer	1.34e-05	0.00114	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.33e-05	0.00113	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—HRAS—uterine cancer	1.32e-05	0.00112	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—AKR1B1—uterine cancer	1.31e-05	0.00111	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—STAR—uterine cancer	1.31e-05	0.00111	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.29e-05	0.0011	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—CXCL8—uterine cancer	1.29e-05	0.00109	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—STAR—uterine cancer	1.28e-05	0.00109	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—AKR1B1—uterine cancer	1.28e-05	0.00109	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—FGFR2—uterine cancer	1.28e-05	0.00109	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.27e-05	0.00108	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.26e-05	0.00107	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.25e-05	0.00106	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.25e-05	0.00106	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.22e-05	0.00103	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—AKT1—uterine cancer	1.16e-05	0.000988	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.15e-05	0.000974	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.12e-05	0.000954	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—STAR—uterine cancer	1.11e-05	0.000943	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—AKR1B1—uterine cancer	1.11e-05	0.000943	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.1e-05	0.000932	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—ESR1—uterine cancer	1.09e-05	0.000929	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.07e-05	0.000907	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.07e-05	0.000907	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.04e-05	0.000883	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.04e-05	0.000881	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—NRAS—uterine cancer	1.03e-05	0.000878	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—POLD1—uterine cancer	1.03e-05	0.000874	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—POLD1—uterine cancer	1.01e-05	0.000855	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—STAR—uterine cancer	9.92e-06	0.000842	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—AKR1B1—uterine cancer	9.92e-06	0.000842	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	9.83e-06	0.000834	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	9.81e-06	0.000832	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	9.81e-06	0.000832	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—AKR1B1—uterine cancer	9.69e-06	0.000822	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—STAR—uterine cancer	9.69e-06	0.000822	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCL2—uterine cancer	9.64e-06	0.000818	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—AKR1C1—uterine cancer	9.64e-06	0.000818	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	9.58e-06	0.000813	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—AKR1C1—uterine cancer	9.42e-06	0.000799	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	9.14e-06	0.000775	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—AKR1B1—uterine cancer	9.05e-06	0.000768	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—STAR—uterine cancer	9.05e-06	0.000768	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—PIK3CA—uterine cancer	9.01e-06	0.000765	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	8.94e-06	0.000759	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—KRAS—uterine cancer	8.91e-06	0.000756	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—POLD1—uterine cancer	8.72e-06	0.00074	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	8.66e-06	0.000734	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—RRM2—uterine cancer	8.59e-06	0.000729	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—RRM2—uterine cancer	8.4e-06	0.000712	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—DCN—uterine cancer	8.34e-06	0.000708	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NDUFB11—uterine cancer	8.25e-06	0.0007	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SRD5A2—uterine cancer	8.25e-06	0.0007	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—PIK3CA—uterine cancer	8.18e-06	0.000694	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—AKR1C1—uterine cancer	8.16e-06	0.000692	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—DCN—uterine cancer	8.15e-06	0.000692	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—ERBB2—uterine cancer	8.04e-06	0.000682	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYP11A1—uterine cancer	7.86e-06	0.000667	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—POLD1—uterine cancer	7.79e-06	0.000661	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—STAR—uterine cancer	7.73e-06	0.000656	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—AKR1B1—uterine cancer	7.73e-06	0.000656	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYP11A1—uterine cancer	7.68e-06	0.000652	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.64e-06	0.000648	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CXCL8—uterine cancer	7.62e-06	0.000647	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—POLD1—uterine cancer	7.6e-06	0.000645	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—HRAS—uterine cancer	7.57e-06	0.000642	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CDKN1B—uterine cancer	7.44e-06	0.000631	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—AKR1C3—uterine cancer	7.42e-06	0.00063	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—AKT1—uterine cancer	7.36e-06	0.000625	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	7.36e-06	0.000624	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—AKR1C1—uterine cancer	7.28e-06	0.000618	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—RRM2—uterine cancer	7.27e-06	0.000617	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—AKR1C3—uterine cancer	7.25e-06	0.000615	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—AKR1C1—uterine cancer	7.11e-06	0.000603	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—POLD1—uterine cancer	7.1e-06	0.000602	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—DCN—uterine cancer	7.06e-06	0.000599	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CTNNB1—uterine cancer	7.03e-06	0.000596	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PTEN—uterine cancer	6.85e-06	0.000581	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	6.76e-06	0.000574	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—AKT1—uterine cancer	6.69e-06	0.000567	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP11A1—uterine cancer	6.65e-06	0.000564	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—AKR1C1—uterine cancer	6.64e-06	0.000563	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	6.54e-06	0.000555	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—EP300—uterine cancer	6.53e-06	0.000554	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—RRM2—uterine cancer	6.49e-06	0.000551	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—RRM2—uterine cancer	6.34e-06	0.000538	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—DCN—uterine cancer	6.3e-06	0.000535	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—AKR1C3—uterine cancer	6.28e-06	0.000533	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—VEGFA—uterine cancer	6.19e-06	0.000525	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—DCN—uterine cancer	6.15e-06	0.000522	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—NRAS—uterine cancer	6.11e-06	0.000519	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—POLD1—uterine cancer	6.07e-06	0.000515	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—STAR—uterine cancer	5.97e-06	0.000506	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—AKR1B1—uterine cancer	5.97e-06	0.000506	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP11A1—uterine cancer	5.94e-06	0.000504	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—RRM2—uterine cancer	5.92e-06	0.000502	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP11A1—uterine cancer	5.79e-06	0.000492	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYP19A1—uterine cancer	5.78e-06	0.00049	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—STK11—uterine cancer	5.78e-06	0.00049	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—DCN—uterine cancer	5.75e-06	0.000488	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—AKR1C1—uterine cancer	5.67e-06	0.000481	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—STK11—uterine cancer	5.65e-06	0.000479	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYP19A1—uterine cancer	5.65e-06	0.000479	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—AKR1C3—uterine cancer	5.61e-06	0.000476	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.52e-06	0.000469	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—AKR1C3—uterine cancer	5.47e-06	0.000464	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP11A1—uterine cancer	5.41e-06	0.000459	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—KRAS—uterine cancer	5.26e-06	0.000446	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—AKR1C3—uterine cancer	5.11e-06	0.000434	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—RRM2—uterine cancer	5.06e-06	0.000429	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—DCN—uterine cancer	4.91e-06	0.000417	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—STK11—uterine cancer	4.89e-06	0.000415	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP19A1—uterine cancer	4.89e-06	0.000415	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PIK3CA—uterine cancer	4.83e-06	0.00041	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—POLD1—uterine cancer	4.68e-06	0.000397	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TP53—uterine cancer	4.68e-06	0.000397	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP11A1—uterine cancer	4.63e-06	0.000392	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.59e-06	0.00039	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—HRAS—uterine cancer	4.47e-06	0.000379	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.38e-06	0.000372	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.38e-06	0.000372	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—AKR1C3—uterine cancer	4.37e-06	0.000371	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—STK11—uterine cancer	4.37e-06	0.000371	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP19A1—uterine cancer	4.37e-06	0.000371	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—MTHFR—uterine cancer	4.34e-06	0.000369	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—STK11—uterine cancer	4.26e-06	0.000362	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP19A1—uterine cancer	4.26e-06	0.000362	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—MTHFR—uterine cancer	4.25e-06	0.00036	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.1e-06	0.000348	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP19A1—uterine cancer	3.98e-06	0.000338	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—STK11—uterine cancer	3.98e-06	0.000338	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—AKT1—uterine cancer	3.95e-06	0.000335	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.91e-06	0.000332	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—RRM2—uterine cancer	3.9e-06	0.000331	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—DCN—uterine cancer	3.79e-06	0.000322	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.74e-06	0.000317	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—MTHFR—uterine cancer	3.68e-06	0.000312	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP11A1—uterine cancer	3.57e-06	0.000303	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.57e-06	0.000303	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—STK11—uterine cancer	3.4e-06	0.000289	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP19A1—uterine cancer	3.4e-06	0.000289	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.37e-06	0.000286	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—MTHFR—uterine cancer	3.28e-06	0.000278	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.24e-06	0.000275	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—MTHFR—uterine cancer	3.2e-06	0.000272	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.19e-06	0.000271	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.05e-06	0.000259	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—MTHFR—uterine cancer	2.99e-06	0.000254	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.89e-06	0.000245	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.64e-06	0.000224	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—STK11—uterine cancer	2.63e-06	0.000223	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.63e-06	0.000223	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—MTHFR—uterine cancer	2.56e-06	0.000217	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PTEN—uterine cancer	2.42e-06	0.000205	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PTEN—uterine cancer	2.36e-06	0.0002	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—EP300—uterine cancer	2.3e-06	0.000196	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.25e-06	0.000191	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—EP300—uterine cancer	2.25e-06	0.000191	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PTEN—uterine cancer	2.05e-06	0.000174	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—MTHFR—uterine cancer	1.97e-06	0.000167	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—EP300—uterine cancer	1.95e-06	0.000166	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PTEN—uterine cancer	1.83e-06	0.000155	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PTEN—uterine cancer	1.78e-06	0.000151	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—EP300—uterine cancer	1.74e-06	0.000148	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CA—uterine cancer	1.7e-06	0.000145	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—EP300—uterine cancer	1.7e-06	0.000144	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CA—uterine cancer	1.67e-06	0.000141	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PTEN—uterine cancer	1.67e-06	0.000141	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—EP300—uterine cancer	1.59e-06	0.000135	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CA—uterine cancer	1.44e-06	0.000122	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PTEN—uterine cancer	1.42e-06	0.000121	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—AKT1—uterine cancer	1.39e-06	0.000118	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—AKT1—uterine cancer	1.36e-06	0.000115	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—EP300—uterine cancer	1.36e-06	0.000115	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.29e-06	0.000109	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CA—uterine cancer	1.26e-06	0.000107	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—AKT1—uterine cancer	1.18e-06	0.0001	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.17e-06	9.97e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PTEN—uterine cancer	1.1e-06	9.32e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—AKT1—uterine cancer	1.05e-06	8.93e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—EP300—uterine cancer	1.05e-06	8.88e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—AKT1—uterine cancer	1.03e-06	8.71e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CA—uterine cancer	1e-06	8.52e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—AKT1—uterine cancer	9.6e-07	8.14e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—AKT1—uterine cancer	8.2e-07	6.96e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CA—uterine cancer	7.75e-07	6.57e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—AKT1—uterine cancer	6.33e-07	5.37e-05	CbGpPWpGaD
